Carzaniga; Laura

Patent Applications and Registrations

Patent applications and USPTO patent grants for Carzaniga; Laura.The latest application filed is for "compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity".

Company Profile

1.10.13

Carzaniga; Laura - Parma IT
Carzaniga; Laura - Roncello MB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 10,196,386 - Rancati , et al. Fe	2019-02-05
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Grant 10,004,728 - Rancati , et al. June 26, 2	2018-06-26
1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors Grant 9,944,612 - Armani , et al. April 17, 2	2018-04-17
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Grant 9,932,338 - Carzaniga , et al. April 3, 2	2018-04-03
Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors Grant 9,931,327 - Armani , et al. April 3, 2	2018-04-03
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20180016267 - RANCATI; Fabio ; et al.	2018-01-18
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20170158694 - CARZANIGA; Laura ; et al.	2017-06-08
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity Grant 9,662,323 - Carzaniga , et al. May 30, 2	2017-05-30
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20170119753 - RANCATI; Fabio ; et al.	2017-05-04
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity Grant 9,579,314 - Rancati , et al. February 28, 2	2017-02-28
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20160346271 - CARZANIGA; Laura ; et al.	2016-12-01
Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors Grant 9,440,954 - Armani , et al. September 13, 2	2016-09-13
Compounds Having Muscarinic Receptor Antagonist And Beta2 Adrenergic Receptor Agonist Activity App 20160235734 - RANCATI; Fabio ; et al.	2016-08-18
Isochromene derivatives as phoshoinositide 3-kinases inhibitors Grant 9,321,776 - Biagetti , et al. April 26, 2	2016-04-26
Derivatives Of 1-phenyl-2-pyridinyl Alkyl Alcohols As Phosphodiesterase Inhibitors App 20160008338 - ARMANI; Elisabetta ; et al.	2016-01-14
Isochromene Derivatives As Phoshoinositide 3-kinases Inhibitors App 20150166549 - Biagetti; Matteo ; et al.	2015-06-18
Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors Grant 9,024,027 - Armani , et al. May 5, 2	2015-05-05
1-phenyl-2-pyridinyl Alkyl Alcohol Derivatives As Phosphodiesterase Inhibitors App 20140155391 - ARMANI; Elisabetta ; et al.	2014-06-05
Derivatives Of 1-phenyl-2-pyridinyl Alkyl Alcohols As Phosphodiesterase Inhibitors App 20140057882 - ARMANI; Elisabetta ; et al.	2014-02-27
Derivatives Of 1-phenyl-2-pyridinyl Alkyl Alcohols As Phosphodiesterase Inhibitors App 20130324501 - ARMANI; Elisabetta ; et al.	2013-12-05
Derivatives Of 1-phenyl-2-pyridinyl Alkyl Alcohols As Phosphodiesterase Inhibitors App 20130102576 - ARMANI; Elisabetta ; et al.	2013-04-25
Derivatives Of 1-phenyl-2-pyridinyl Alkyl Alcohols As Phosphodiesterase Inhibitors App 20130005716 - Armani; Elisabetta ; et al.	2013-01-03
New No Releasing Steroids Derivatives App 20110130376 - Benedini; Francesca ; et al.	2011-06-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.